1. Home
  2. ABCB vs ACAD Comparison

ABCB vs ACAD Comparison

Compare ABCB & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ameris Bancorp

ABCB

Ameris Bancorp

HOLD

Current Price

$78.43

Market Cap

5.1B

Sector

Finance

ML Signal

HOLD

Logo ACADIA Pharmaceuticals Inc.

ACAD

ACADIA Pharmaceuticals Inc.

HOLD

Current Price

$26.86

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCB
ACAD
Founded
1971
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
4.6B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
ABCB
ACAD
Price
$78.43
$26.86
Analyst Decision
Buy
Buy
Analyst Count
7
23
Target Price
$79.57
$29.39
AVG Volume (30 Days)
407.7K
1.5M
Earning Date
01-29-2026
11-05-2025
Dividend Yield
1.03%
N/A
EPS Growth
20.70
98.53
EPS
5.77
1.54
Revenue
$1,130,299,000.00
$1,047,118,000.00
Revenue This Year
$13.82
$15.16
Revenue Next Year
$4.87
$11.42
P/E Ratio
$13.43
$17.47
Revenue Growth
7.96
12.69
52 Week Low
$48.27
$13.40
52 Week High
$78.99
$27.73

Technical Indicators

Market Signals
Indicator
ABCB
ACAD
Relative Strength Index (RSI) 62.21 64.79
Support Level $76.79 $26.60
Resistance Level $78.99 $27.47
Average True Range (ATR) 1.45 0.81
MACD 0.09 -0.02
Stochastic Oscillator 82.44 73.25

Price Performance

Historical Comparison
ABCB
ACAD

About ABCB Ameris Bancorp

Ameris Bancorp is a bank holding company that operates through Ameris Bank, its subsidiary. The company operates branches in Georgia, Alabama, Florida, and South Carolina. It offers traditional banking services such as business banking, personal banking, checking, savings, mobile banking, and others. The bank is organized into four segments: the Banking Division, the Retail Mortgage Division, the Warehouse Lending Division and the Premium Finance Division. The company generates majority of its revenue from the banking division. Ameris intends to acquire banks in its geographic region to increase its market share and expand beyond its current market.

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.

Share on Social Networks: